Outlook TherapeuticsOTLK 
$1.473.52%24h
3.52%24h
Global rank12851
Market cap$367.76M
Change 7d-71.12%
YTD Performance-
SP500 benchmark
P/E-6.13
P/S0
Revenue$0
Earnings-$58.98M
Dividend yield-
Main Sector
Healthcare
Category
Outlook Therapeutics (OTLK) Cash on Hand
OTLK Cash on Hand in 2022: $23.39M
According to Outlook Therapeutics latest financial reports the cash on hand of OTLK is $23.39M, an increase of 34.46% to 2022. At the end of 2022 company had $17.40M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
OTLK Cash on Hand History from 2018 to 2023
-
Value:-
OTLK Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $23.39M | 34.46% |
| 2022 | $17.40M | 20.17% |
| 2021 | $14.48M | 15.49% |
| 2020 | $12.54M | 56.40% |
| 2019 | $8.02M | 366.73% |
| 2018 | $1.72M | - |
View the Top Cash on Hand Companies 
